AMANDA GILLESPIE: Open Payments
NPI 1477942092 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 3 payments from 3 companies in 2025. Trend: 2023 $347 · 2024 $289 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 1 | $101 |
| Lundbeck LLC | 1 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
Products named: NUPLAZID, REXULTI, GVOKE HYPOPEN.
Industry payments across MO — which companies pay providers there.
